Literature DB >> 14351974

TUBERCULIN reaction size on five consecutive days.

.   

Abstract

The present paper gives the results of a study on tuberculin reaction size-erythema and induration-at different intervals after intradermal testing with 1 TU.In the course of tuberculin-testing some 18,000 textile workers in Mehalla el Kobra, Egypt, the tuberculin reactions of 417 men were read daily for five days after the tests had been given. The successive readings were made by the same observer without reference to his previous readings.No difference of any practical significance was found between the results of readings made on the second through the fifth day. Almost all the reactions of over 6 mm of induration on any one day (except the first) remained above 6 mm on the subsequent days, and those measuring 0-6 mm did not exceed 6 mm on the later days. Thus, whether the reactions had been read on the second, third, fourth, or fifth day, essentially the same persons would have been classified as positive and negative according to the induration-reaction size.Erythema could have served as well as induration for separating the study population into the same two groups, had 0-8 mm of erythema been defined as negative and erythema of 9 mm or more as positive for reactions read on the second through the fifth day.In tuberculin surveys of the population under study there would thus have been no need to adhere to a fixed reading interval.The material included in the present paper illustrates how the results of a relatively small and inexpensive preliminary study may serve to simplify and rationalize subsequent large-scale work.

Entities:  

Keywords:  TUBERCULIN REACTION

Mesh:

Substances:

Year:  1955        PMID: 14351974      PMCID: PMC2542340     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.

Authors:  Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; David J Horne; Grace John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

Review 2.  Tuberculin test.

Authors:  V K Chadha
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

3.  Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.

Authors:  Samantha R Kaplan; Jaclyn N Escudero; Jerphason Mecha; Barbra A Richardson; Elizabeth Maleche-Obimbo; Daniel Matemo; John Kinuthia; Grace C John-Stewart; Sylvia M LaCourse
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

4.  Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests.

Authors:  Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; Grace John-Stewart; David J Horne
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

Review 5.  Update on cutaneous tuberculosis.

Authors:  Maria Fernanda Reis Gavazzoni Dias; Fred Bernardes Filho; Maria Victória Quaresma; Leninha Valério do Nascimento; José Augusto da Costa Nery; David Rubem Azulay
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

6.  Induration or erythema diameter not less than 5 mm as results of recombinant fusion protein ESAT6-CFP10 skin test for detecting M. tuberculosis infection.

Authors:  Hui Zhang; Ling Wang; Feng Li; Shuihua Lu; Jielai Xia
Journal:  BMC Infect Dis       Date:  2020-09-18       Impact factor: 3.090

7.  Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.

Authors:  Jill K Gersh; Ruanne V Barnabas; Daniel Matemo; John Kinuthia; Zachary Feldman; Sylvia M Lacourse; Jerphason Mecha; Alex J Warr; Maureen Kamene; David J Horne
Journal:  BMC Infect Dis       Date:  2021-02-25       Impact factor: 3.090

8.  Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.

Authors:  Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jaclyn N Escudero; Thomas R Hawn; Grace C John-Stewart
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.